[Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].

Ugeskr Laeger

Odense Universitetshospital, Naevusklinikken, Dermatologisk Afdeling, og Hørsholm Sygehus, Dermatologisk Klinik.

Published: September 2005

Imiquimod is an immune system-modifying drug that switches the immune system to a Th1 response, enabling it to defeat virus-infected and neoplastic cells. We report on a 94-year-old woman with a large lentigo maligna (LM) on her cheek whom we treated with imiquimod 5% cream. Dermoscopy was used to identify the most suspect areas of the lesion for biopsy and in follow-up. By week 19 the lesion was cleared, and no remnants of the lesion were seen by dermoscopy or histology. Published LM cases treated with imiquimod are reviewed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

lentigo maligna
8
treated imiquimod
8
[imiquimod treatment
4
treatment lentigo
4
maligna dermoscopic
4
dermoscopic histologic
4
histologic clearance]
4
clearance] imiquimod
4
imiquimod immune
4
immune system-modifying
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!